Silverfin false 29/01/2023 30/01/2022 29/01/2023 Malcolm Alexander Loudon 24/01/2017 16 October 2023 The principal activity of the Company during the financial year was surgical consulting. SC555472 2023-01-29 SC555472 bus:Director1 2023-01-29 SC555472 2022-01-29 SC555472 core:CurrentFinancialInstruments 2023-01-29 SC555472 core:CurrentFinancialInstruments 2022-01-29 SC555472 core:ShareCapital 2023-01-29 SC555472 core:ShareCapital 2022-01-29 SC555472 core:RetainedEarningsAccumulatedLosses 2023-01-29 SC555472 core:RetainedEarningsAccumulatedLosses 2022-01-29 SC555472 core:OtherResidualIntangibleAssets 2022-01-29 SC555472 core:OtherResidualIntangibleAssets 2023-01-29 SC555472 core:ComputerEquipment 2022-01-29 SC555472 core:ComputerEquipment 2023-01-29 SC555472 bus:OrdinaryShareClass1 2023-01-29 SC555472 2022-01-30 2023-01-29 SC555472 bus:FullAccounts 2022-01-30 2023-01-29 SC555472 bus:SmallEntities 2022-01-30 2023-01-29 SC555472 bus:AuditExemptWithAccountantsReport 2022-01-30 2023-01-29 SC555472 bus:PrivateLimitedCompanyLtd 2022-01-30 2023-01-29 SC555472 bus:Director1 2022-01-30 2023-01-29 SC555472 core:OtherResidualIntangibleAssets core:TopRangeValue 2022-01-30 2023-01-29 SC555472 core:OtherResidualIntangibleAssets 2022-01-30 2023-01-29 SC555472 core:ComputerEquipment core:TopRangeValue 2022-01-30 2023-01-29 SC555472 2021-01-30 2022-01-29 SC555472 core:ComputerEquipment 2022-01-30 2023-01-29 SC555472 bus:OrdinaryShareClass1 2022-01-30 2023-01-29 SC555472 bus:OrdinaryShareClass1 2021-01-30 2022-01-29 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC555472 (Scotland)

LOUDON CLINICAL CONSULTING LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 29 JANUARY 2023
PAGES FOR FILING WITH THE REGISTRAR

LOUDON CLINICAL CONSULTING LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 29 JANUARY 2023

Contents

LOUDON CLINICAL CONSULTING LTD

BALANCE SHEET

AS AT 29 JANUARY 2023
LOUDON CLINICAL CONSULTING LTD

BALANCE SHEET (continued)

AS AT 29 JANUARY 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 4 1,080 0
1,080 0
Current assets
Debtors 20,054 1
Cash at bank and in hand 5 22,354 21,314
42,408 21,315
Creditors: amounts falling due within one year 6 ( 11,292) ( 6,543)
Net current assets 31,116 14,772
Total assets less current liabilities 32,196 14,772
Provision for liabilities ( 205) 0
Net assets 31,991 14,772
Capital and reserves
Called-up share capital 7 1 1
Profit and loss account 31,990 14,771
Total shareholder's funds 31,991 14,772

For the financial year ending 29 January 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Loudon Clinical Consulting Ltd (registered number: SC555472) were approved and authorised for issue by the Director on 16 October 2023. They were signed on its behalf by:

Malcolm Alexander Loudon
Director
LOUDON CLINICAL CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 29 JANUARY 2023
LOUDON CLINICAL CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 29 JANUARY 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Loudon Clinical Consulting Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Oak Lodge Oak Lodge, Banavie, Fort William, PH33 7PB, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 4 years straight line
Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 3.3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, are recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 30 January 2022 4,161 4,161
At 29 January 2023 4,161 4,161
Accumulated amortisation
At 30 January 2022 4,161 4,161
At 29 January 2023 4,161 4,161
Net book value
At 29 January 2023 0 0
At 29 January 2022 0 0

4. Tangible assets

Computer equipment Total
£ £
Cost
At 30 January 2022 800 800
Additions 1,144 1,144
Disposals ( 800) ( 800)
At 29 January 2023 1,144 1,144
Accumulated depreciation
At 30 January 2022 800 800
Charge for the financial year 64 64
Disposals ( 800) ( 800)
At 29 January 2023 64 64
Net book value
At 29 January 2023 1,080 1,080
At 29 January 2022 0 0

5. Cash and cash equivalents

2023 2022
£ £
Cash at bank and in hand 22,354 21,314

6. Creditors: amounts falling due within one year

2023 2022
£ £
Trade creditors 0 1,980
Taxation and social security 5,673 ( 23)
Other creditors 5,619 4,586
11,292 6,543

7. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1

8. Related party transactions

Transactions with the entity's director

2023 2022
£ £
Amounts due to director 3,583 2,294

The above amount is interest free and has no fixed terms of repayment.